Pyxis Oncology, Inc. Other Non-Current Assets
Pyxis Oncology, Inc. (PYXS) had Other Non-Current Assets of $449.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2023-03-22
- 2022-03-31: Other Assets, Noncurrent $449.00K.
- 2021-12-31: Other Assets, Noncurrent $109.00K.
- 2021-09-30: Other Assets, Noncurrent $109.00K.
- 2020-12-31: Other Assets, Noncurrent $109.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2022-03-31 | $449.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $109.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $109.00K 10-Q · filed 2021-11-15 |
| 2020-12-31 | $109.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |